SEC Company Response from IMMUNIC, INC. (IMUX) (CIK 0001280776) (IMUX) — Feb 13, 2019
IMMUNIC, INC. (IMUX) (CIK 0001280776)
Date: Feb. 13, 2019 · CIK: 0001280776 · Accession: 0001193125-19-037823
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-229510
Letter
Vital Therapies, Inc.
15222-B Avenue of Science
San Diego, California 92128
February 13, 2019
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Todd Schiffman
RE: Vital Therapies, Inc.
Registration Statement on Form S-4
File No. 333-229510
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Vital Therapies, Inc. (the “Company”) hereby requests that the effective date of the above-captioned registration statement on Form S-4 (the “Registration Statement”), be accelerated to 4:00 p.m., Eastern Time, on February 14, 2019, or as soon thereafter as may be practicable.
Very truly yours,
Vital Therapies, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Vital Therapies, Inc. 15222-B Avenue of Science San Diego, California 92128 February 13, 2019 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Todd Schiffman RE: Vital Therapies, Inc. Registration Statement on Form S-4 File No. 333-229510 Request for Acceleration of Effectiveness Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Vital Therapies, Inc. (the “Company”) hereby requests that the effective date of the above-captioned registration statement on Form S-4 (the “Registration Statement”), be accelerated to 4:00 p.m., Eastern Time, on February 14, 2019, or as soon thereafter as may be practicable. Very truly yours, Vital Therapies, Inc. By: /s/ Michael V. Swanson Michael V. Swanson Executive Vice President and Chief Financial Officer cc: Gabriella Lombardi